News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Farrell Michael J.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.
Txns:
| Granted 321 options to buy
@ $0 |
|
08/18/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC
Txns:
| Granted 12,430 shares
@ $0 |
|
08/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC
Txns:
| Sold 5,675 shares
@ $183.1977, valued at
$1M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/12/2023 |
4/A
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.
Txns:
| Granted 247 options to buy
@ $0 |
|
07/05/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.
Txns:
| Granted 213 options to buy
@ $0 |
|
06/16/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC
Txns:
| Sold 5,675 shares
@ $217.3949, valued at
$1.2M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
05/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC
Txns:
| Sold 5,675 shares
@ $232.1041, valued at
$1.3M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
05/16/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.
Txns:
| Granted 500 options to buy
@ $0 Granted 951 restricted stock units
@ $0 |
|
05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/04/2023 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.
Txns:
| Granted 243 options to buy
@ $0 |
|
03/17/2023 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC
Txns:
| Sold 5,675 shares
@ $206.9517, valued at
$1.2M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
03/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
4
| Farrell Michael J. (Director) has filed a Form 4 on ZIMMER BIOMET HOLDINGS, INC.
Txns:
| Granted 294 options to buy
@ $0 |
|
09/19/2022 |
4
| Farrell Michael J. (CEO) has filed a Form 4 on RESMED INC
Txns:
| Sold 5,675 shares
@ $228.9579, valued at
$1.3M
Exercised 5,675 options to buy
@ $57.76, valued at
$327.8k
|
|
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|